Novotech Revenue and Competitors

Claim your profile

Sydney, AUS



Total Funding



Estimated Revenue & Valuation

  • Novotech's estimated annual revenue is currently $230.9M per year.(i)
  • Novotech's estimated revenue per employee is $155,000

Employee Data

  • Novotech has 1490 Employees.(i)
  • Novotech grew their employee count by 47% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation

Headquartered in Sydney, Australia and focused exclusively on the Asia Pacific, Novotech is internationally recognized as a leading regional full-service CRO. With the increasing pace of globalization in drug development, Novotech's expertise in the vibrant and fast growing Asian region was instrumental in the success of hundreds of phase I-IV clinical trials. With operations in Australia, New Zealand, South Africa, Hong Kong, China, India, Malaysia, the Philippines, Singapore, South Korea, Taiwan and Thailand, Novotech's service offering is recognized for its quality by our clients and industry analyst groups. Our History Established in 1996, Novotech is Australia's largest independent CRO. The Australian Head Office is in Sydney, with regional offices in Melbourne and Brisbane - providing easy access to the most important population centers in Australia. Supported by regional staff across the country and in New Zealand, our coverage of the Australia/New Zealand region is comprehensive. With Asian services launched in 2007, Novotech's operations provide access to the most dynamic and fast growing clinical research hubs in the region. In addition, we offer worldwide reach to our clients through key partnerships and strategic alliances, with partners in the US, Canada, Europe, and China. The combination of a relatively small, flexible CRO, coupled with the ability to confidently manage very large projects allows us to move a project from initial planning stage to recruitment with dramatic speed.



Total Funding


Number of Employees


Revenue (est)


Employee Growth %





Novotech News

2022-04-20 - Gut and Digestive Health Ingredient Market Size And Forecast ...

... Size And Forecast 2022-2030 | Key Players – Archer Daniels Midland Company, UAS Labs LLC, Novotech Nutraceuticals, Tate & Lyle PLC.

2022-04-17 - Global DHA Powder for Food and Beverage Market 2022 ...

DSM; Stepan Company; Novotech Nutraceuticals; Lonza; Arjuna Natural; Runke; Fuxing; Kingdomway; Cabio; Tianhecheng; Yidie. Geographically, the market is...

2022-04-13 - Copper Gluconate Market Size, Scope And Forecast | Leading ...

Novotech Nutraceuticals, Jost Chemical, Kelatron, Zygosome, Fuso Chemical. Copper Gluconate Market Segmentation: By the product type,...

2021-02-01 - Sequoia, GIC invest in TPG-backed Novotech at $2.3b valuation

Premium Sequoia Capital and Singapore sovereign fund GIC Pte are among investors that agreed to buy a stake in clinical research and testing provider Novotech Pty from TPG, people with knowledge of the matter said. Continue reading this story with a subscription to DealStreetAsia. Subscribe ...

2018-10-17 - Novotech beefs up Asia-Pa­cif­ic CRO of­fer­ing with new buy­out as re­gion’s bio­phar­ma busi­ness booms

→ Asia-Pa­cif­ic CRO Novotech is ex­pand­ing, buy­ing out CRO Clin­i­cal Net­work Ser­vices as it builds up its ear­ly- to late-stage tri­al net­work in the re­gion. CNS’ 140 staffers in Aus­tralia, New Zealand and the US will con­tin­ue to op­er­ate as an in­de­pen­dent unit, work­ing with the ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding